Atlas Trials

Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia

Clinical trial NCT00492336 · COMPLETED

Trial details

NCT number
NCT00492336
Sponsor
University of Maryland, Baltimore
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia
Start date
2007-01-01
Primary completion
2012-02-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.